NK model simulation study of intelligent manufacturing transformation path selection in pharmaceutical manufacturing enterprises
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
NK model simulation study of intelligent manufacturing transformation path selection in pharmaceutical manufacturing enterprises ; volume:14 ; number:1 ; day:23 ; month:8 ; year:2024 ; pages:1-20 ; date:12.2024
Scientific reports ; 14, Heft 1 (23.8.2024), 1-20, 12.2024
- Urheber
-
Zhu, Wei
Ouyang, Ping
Ke, Xue
Qiu, Shanshan
Li, Shuqin
Jiang, Zhensong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-70502-7
- URN
-
urn:nbn:de:101:1-2411120905569.433404499419
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhu, Wei
- Ouyang, Ping
- Ke, Xue
- Qiu, Shanshan
- Li, Shuqin
- Jiang, Zhensong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synchronisation mobiler Stationen in Nahbereichsfunknetzen
Strengthening the Ability of General Hospital Neurology Departments to Treat Neuropsychiatric Diseases and Mental Disorders
Effectiveness of non-pharmaceutical interventions for COVID-19 in USA
Computational developments in microRNA-regulated protein-protein interactions
A mathematical conjecture associates Martian TARs with sand ripples
Regulation of the Endogenous Opiate Signaling Pathway against Oxidative Stress and Inflammation: A Considerable Approach for Exploring Preclinical Treatment of Parkinson’s Disease
Continuous processing in pharmaceutical manufacturing
Optimal designs for dose-response models with restricted design spaces
Compound Optimal Designs for Percentile Estimation in Dose-Response Models with Restricted Design Intervals
On the Equivalence of Optimality Design Criteria for the Placebo-Treatment Problem
Geometric construction of optimal designs for dose-responsemodels with two parameters
Phase self-aligned continuous-variable measurement-device-independent quantum key distribution
Synchronisation mobiler Stationen in Nahbereichsfunknetzen
Strengthening the Ability of General Hospital Neurology Departments to Treat Neuropsychiatric Diseases and Mental Disorders
Effectiveness of non-pharmaceutical interventions for COVID-19 in USA
Computational developments in microRNA-regulated protein-protein interactions
A mathematical conjecture associates Martian TARs with sand ripples
Regulation of the Endogenous Opiate Signaling Pathway against Oxidative Stress and Inflammation: A Considerable Approach for Exploring Preclinical Treatment of Parkinson’s Disease
Continuous processing in pharmaceutical manufacturing
Optimal designs for dose-response models with restricted design spaces
Compound Optimal Designs for Percentile Estimation in Dose-Response Models with Restricted Design Intervals
On the Equivalence of Optimality Design Criteria for the Placebo-Treatment Problem
Geometric construction of optimal designs for dose-responsemodels with two parameters
Phase self-aligned continuous-variable measurement-device-independent quantum key distribution
Synchronisation mobiler Stationen in Nahbereichsfunknetzen
Strengthening the Ability of General Hospital Neurology Departments to Treat Neuropsychiatric Diseases and Mental Disorders
Effectiveness of non-pharmaceutical interventions for COVID-19 in USA
Computational developments in microRNA-regulated protein-protein interactions
A mathematical conjecture associates Martian TARs with sand ripples
Regulation of the Endogenous Opiate Signaling Pathway against Oxidative Stress and Inflammation: A Considerable Approach for Exploring Preclinical Treatment of Parkinson’s Disease
Continuous processing in pharmaceutical manufacturing
Optimal designs for dose-response models with restricted design spaces
Compound Optimal Designs for Percentile Estimation in Dose-Response Models with Restricted Design Intervals
On the Equivalence of Optimality Design Criteria for the Placebo-Treatment Problem
Geometric construction of optimal designs for dose-responsemodels with two parameters